Antagonism of mineralocorticoid receptor ameliorates systemic insulin resistance and steatohepatitis in a novel mouse model of non-alcoholic steatohepatitis (NASH) utilizing liver-specific SREBP1c transgenic mice.

Activity: Talk or presentation › Oral presentation

Period	2011/01/12 → 2011/01/17
Event title	Wada T., Miyashita Y., Sasaki M., Ishii Y., Sasahara M., Tsuneki H. and Sasaoka T.
Event type	Other